In pancreatic cancer cells, overexpression of miR-27b leads to downregulation of CYP3A4 protein and results in drug resistance to cyclophosphamide because CYP3A4 is necessary for drug activation (165). This evidence concerns the gene CYP3A4 and pancreatic neoplasm.